Dr. Anish Chandarana: ARNI with beta-blockers ahead of SGLT2-i would be the game changer 
Dr. Prafulla Kerkar: Adding Vericiguat with SGLT2-I and beta-blocker instead of ARNI would be the safest strategy as the starting choice
Dr. C. K. Ponde: Beta-blocker with SGLT2-i ahead of ACE/ARB is less likely to cause hypotension and other side-effects and should be chosen ahead of others

Heart Failure

Dr. Abhisheka Tripathi: TICAGRELOR is an all season antiplatelet without higher bleeding risk with higher efficacy
Dr. Sarath Chandra: PRASUGREL is the preferred Antiplatelet given for his risk profile!
Dr. C. K. Ponde: Clopidogrel is the safest choice amongst the three options

Dr. C.K. Ponde

2

745

11.8k

4.5

Sessions Taken

904

4.6

376

4.5